Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ABUSABUS
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ARBUTUS BIOPHARMA CORP

GEODE CAPITAL MANAGEMENT, LLC holds 4.1M shares of ABUS (ARBUTUS BIOPHARMA CORP), worth $19.8M as of 2026-Q2. The position was increased (+9.2% shares). ABUS represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$19.8M

Current Shares

4.1M

Total Value Change

+$6.5M

Total Shares Change

+669,091

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.1M
+9.2%
$19.8M0.0%$4.80
31
2026-Q1
Increased
3.8M
+2.6%
$17M0.0%$4.69
29
2025-Q4
Increased
3.7M
+0.3%
$17.7M0.0%$4.62
28
2025-Q3
Increased
3.7M
+0.8%
$16.6M0.0%$4.46
28
2025-Q2
Increased
3.6M
+2.7%
$11.2M0.0%$3.13
29
2025-Q1
Increased
3.5M
+1.7%
$12.4M0.0%$3.50
28
2024-Q4
Increased
3.5M
+1.0%
$11.4M0.0%$3.20
28
2024-Q3
Increased
3.4M
+4.1%
$13.3M0.0%$3.83
29

Other major holders of ABUS: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used